Brukinsa Capsule
Product Images NDC 72579-011

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brukinsa (NDC 72579-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Beone Medicines Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Brukinsa 01)

Chemical structure diagram of zanubrutinib, the active ingredient in BRUKINSA tablets. The structure features multiple rings, including aromatic and nitrogen-containing heterocycles, as well as oxygen and amine functional groups.*

FDA Label Image

Principal Display Panel (80 mg Capsule Bottle Label)

Packaging label for Brukinsa zanubrutinib capsules, 80 mg strength. The label indicates the product is supplied in a package containing 120 capsules. It includes storage instructions and a warning to keep out of reach of children. The labeler is BeiGene USA, Inc., San Mateo, CA, USA. The label also advises not to open, break, or chew the capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.